Evidence map›Paper›PMID 28643572›Full record

ArticleAIDS care2018

Distinctive barriers to antiretroviral therapy adherence among non-adherent adolescents living with HIV in Botswana.

Elizabeth Yang, Seipone Mphele, Neo Moshashane, Boineelo Bula, Jennifer Chapman, Harriet Okatch, Ed Pettitt, Ontibile Tshume, Tafireyi Marukutira, Gabriel Anabwani and 1 more

Abstract read
In one paragraph

Article in AIDS care, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Elizabeth Yanga Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA , USA.
Seipone Mpheleb Department of Psychology , University of Botswana , Gaborone , Botswana.
Neo Moshashaneb Department of Psychology , University of Botswana , Gaborone , Botswana.
Boineelo Bulab Department of Psychology , University of Botswana , Gaborone , Botswana.
Jennifer Chapmanc Children's Hospital of Philadelphia , Philadelphia , PA , USA.
Harriet Okatcha Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA , USA.
Ed Pettitte Botswana-Baylor Children's Clinical Centre of Excellence , Gaborone , Botswana.
Ontibile Tshumee Botswana-Baylor Children's Clinical Centre of Excellence , Gaborone , Botswana.
Tafireyi Marukutirae Botswana-Baylor Children's Clinical Centre of Excellence , Gaborone , Botswana.
Gabriel Anabwanie Botswana-Baylor Children's Clinical Centre of Excellence , Gaborone , Botswana.
Elizabeth Lowenthalc Children's Hospital of Philadelphia , Philadelphia , PA , USA.
Botswana-Baylor Children's Clinical Center of Excellence · BWUniversity of Botswana · BWChildren's Hospital of Philadelphia · USUniversity of Pennsylvania · US

Funding

Targeted Monitoring and Determinants of Adherence in Adolescents with HIVK23MH095669 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI LOWENTHAL, ELIZABETH DAWN · 2012 to 2016
$874k
NIMH NIH HHS K23 MH095669
6 · The paper itself

Abstract

Levels of adherence to HIV treatment are lower among adolescents compared with older and younger individuals receiving similar therapies. We purposely sampled the most and least adherent adolescents from a 300-adolescent longitudinal HIV treatment adherence study in Gaborone, Botswana. Multiple objective and subjective measures of adherence were available and study participants were selected based on sustained patterns of either excellent or poor adherence over a one-year period. Focus group discussions (FGD) and in-depth interviews (IDI) were conducted with the adolescents and a subset of their caregivers with the goal of revealing barriers and facilitators of adherence. Focus groups were segregated by adherence classification of the participants. Following coding of transcripts, matrices were developed based on participants' adherence classifications in order to clarify differences in themes generated by individuals with different adherence characteristics. 47 adolescents and 25 adults were included. The non-adherent adolescents were older than the adherent adolescents (median age 18 years (IQR 16-19) vs. 14 years (IQR 12-15 years)), with median time on treatment near 10 years in both groups. Interference with daily activities, concerns about stigma and discrimination, side effects, denial of HIV status, and food insecurity arose as challenges to adherence among both those who were consistently adherent and those who were poorly-adherent to their medications. Low outcome expectancy, treatment fatigue, mental health and substance use problems, and mismatches between desired and received social support were discussed only among poorly adherent adolescents and their caregivers. Challenges raised only among adolescents and caregivers in the non-adherent groups are hypothesis-generating, identifying areas that may have a greater contribution to poor outcomes than challenges faced by both adherent and non-adherent adolescents. The contribution of these factors to poor outcomes should be explored in future studies.

Indexed as

Discrimination, PsychologicalDrug MonitoringSocial StigmaAdolescentAntiretroviral Therapy, Highly ActiveBotswanaCaregiversFemaleFocus GroupsHIV InfectionsHumansInterviews as TopicLongitudinal StudiesMaleMedication AdherencePain Managementmiscarried helpingOutcome expectancysocial supportsupervisiontreatment fatigue

Identifiers

PMID28643572
PMCPMC6083824
OpenAlexW2668573456

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.